156 related articles for article (PubMed ID: 31286348)
1. Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [
Vetel S; Vercouillie J; Buron F; Vergote J; Tauber C; Busson J; Chicheri G; Routier S; Sérrière S; Chalon S
Mol Imaging Biol; 2020 Apr; 22(2):348-357. PubMed ID: 31286348
[TBL] [Abstract][Full Text] [Related]
2. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of α
Hillmer AT; Li S; Zheng MQ; Scheunemann M; Lin SF; Nabulsi N; Holden D; Pracitto R; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Esterlis I; Cosgrove KP; Brust P; Carson RE; Huang Y
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1042-1050. PubMed ID: 28120003
[TBL] [Abstract][Full Text] [Related]
4. High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using
Coughlin JM; Rubin LH; Du Y; Rowe SP; Crawford JL; Rosenthal HB; Frey SM; Marshall ES; Shinehouse LK; Chen A; Speck CL; Wang Y; Lesniak WG; Minn I; Bakker A; Kamath V; Smith GS; Albert MS; Azad BB; Dannals RF; Horti A; Wong DF; Pomper MG
J Nucl Med; 2020 Mar; 61(3):423-426. PubMed ID: 31420499
[TBL] [Abstract][Full Text] [Related]
5. Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.
Gao Y; Kellar KJ; Yasuda RP; Tran T; Xiao Y; Dannals RF; Horti AG
J Med Chem; 2013 Oct; 56(19):7574-89. PubMed ID: 24050653
[TBL] [Abstract][Full Text] [Related]
6. A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.
Teodoro R; Scheunemann M; Deuther-Conrad W; Wenzel B; Fasoli FM; Gotti C; Kranz M; Donat CK; Patt M; Hillmer A; Zheng MQ; Peters D; Steinbach J; Sabri O; Huang Y; Brust P
Molecules; 2015 Oct; 20(10):18387-421. PubMed ID: 26473809
[TBL] [Abstract][Full Text] [Related]
7. Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.
Wong DF; Kuwabara H; Horti AG; Roberts JM; Nandi A; Cascella N; Brasic J; Weerts EM; Kitzmiller K; Phan JA; Gapasin L; Sawa A; Valentine H; Wand G; Mishra C; George N; McDonald M; Lesniak W; Holt DP; Azad BB; Dannals RF; Kem W; Freedman R; Gjedde A
Int J Neuropsychopharmacol; 2018 Jul; 21(7):656-667. PubMed ID: 29522184
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [
Donat CK; Hansen HH; Hansen HD; Mease RC; Horti AG; Pomper MG; L'Estrade ET; Herth MM; Peters D; Knudsen GM; Mikkelsen JD
Molecules; 2020 Mar; 25(6):. PubMed ID: 32245032
[TBL] [Abstract][Full Text] [Related]
9. 18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.
Horti AG; Gao Y; Kuwabara H; Wang Y; Abazyan S; Yasuda RP; Tran T; Xiao Y; Sahibzada N; Holt DP; Kellar KJ; Pletnikov MV; Pomper MG; Wong DF; Dannals RF
J Nucl Med; 2014 Apr; 55(4):672-7. PubMed ID: 24556591
[TBL] [Abstract][Full Text] [Related]
10. Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.
Horti AG
Biochem Pharmacol; 2015 Oct; 97(4):566-575. PubMed ID: 26232729
[TBL] [Abstract][Full Text] [Related]
11. Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.
Wong DF; Kuwabara H; Pomper M; Holt DP; Brasic JR; George N; Frolov B; Willis W; Gao Y; Valentine H; Nandi A; Gapasin L; Dannals RF; Horti AG
Mol Imaging Biol; 2014 Oct; 16(5):730-8. PubMed ID: 25145965
[TBL] [Abstract][Full Text] [Related]
12. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
[TBL] [Abstract][Full Text] [Related]
13. The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [
Coughlin JM; Du Y; Rosenthal HB; Slania S; Min Koo S; Park A; Solomon G; Vranesic M; Antonsdottir I; Speck CL; Rootes-Murdy K; Lerner A; Rowe SP; Wang Y; Lesniak WG; Minn I; Bakker A; Smith GS; Dannals RF; Kuwabara H; Horti A; Wong DF; Pomper MG
Neuroimage; 2018 Jan; 165():118-124. PubMed ID: 28993233
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.
Sérrière S; Doméné A; Vercouillie J; Mothes C; Bodard S; Rodrigues N; Guilloteau D; Routier S; Page G; Chalon S
Front Med (Lausanne); 2015; 2():61. PubMed ID: 26389120
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of
Lepelletier FX; Vandesquille M; Asselin MC; Prenant C; Robinson AC; Mann DMA; Green M; Barnett E; Banister SD; Mottinelli M; Mesangeau C; McCurdy CR; Fricke IB; Jacobs AH; Kassiou M; Boutin H
Theranostics; 2020; 10(18):7938-7955. PubMed ID: 32724451
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
17. Development of
Nag S; Miranda-Azpiazu P; Jia Z; Datta P; Arakawa R; Moein MM; Yang Z; Tu Y; Lemoine L; Ågren H; Nordberg A; Långström B; Halldin C
ACS Chem Neurosci; 2022 Feb; 13(3):352-362. PubMed ID: 35020351
[TBL] [Abstract][Full Text] [Related]
18. PET tracers for imaging brain α7 nicotinic receptors: an update.
Chalon S; Vercouillie J; Guilloteau D; Suzenet F; Routier S
Chem Commun (Camb); 2015 Oct; 51(80):14826-31. PubMed ID: 26359819
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.
Schmaljohann J; Gündisch D; Minnerop M; Bucerius J; Joe A; Reinhardt M; Guhlke S; Biersack HJ; Wüllner U
Nucl Med Biol; 2006 Apr; 33(3):305-9. PubMed ID: 16631078
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
